Litcius/Paper detail

Design and Synthesis of Pyrrolo[2,3-<i>d</i>]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate

D.S. Williamson, Garrick P. Smith, Gitte Kobberøe Mikkelsen, Thomas Jensen, P. Acheson-Dossang, Lassina Badolo, Simon T. Bedford, Victoria Chell, I‐Jen Chen, P. Dokurno, Morten Hentzer, Samantha Newland, Stuart Ray, T. Shaw, A.E. Surgenor, Lindsey Terry, Yikang Wang, Kenneth Vielsted Christensen

2021Journal of Medicinal Chemistry38 citationsDOIOpen Access PDF

Abstract

demonstrated high potency and exquisite selectivity for LRRK2 and utility as chemical probes for the study of LRRK2 inhibition.

Topics & Concepts

ChemistryLRRK2KinaseProtein kinase domainStereochemistryLeucine-rich repeatPotencyIn vivoMutantBiochemistryIn vitroMutationBiologyGeneBiotechnologyParkinson's Disease Mechanisms and TreatmentsMicrobial Natural Products and BiosynthesisFungal and yeast genetics research